What They Don’t Teach You In School About Corporate Patent Monetization

“Patent monetization is available to those rare companies with the engineering prowess to develop technologies that markets choose to adopt.”

monetizationEach year, companies invest significant financial resources building and maintaining patent portfolios. But instead of contributing to the bottom line, the patent portfolio often evolves into a growing cost center burdened by maintenance fees, prosecution expenses, and legal overhead. The patents protect some of the company’s products, and make nice plaques for the corporate hallways, but serve little other purpose.

Patent monetization offers an opportunity to reverse this dynamic. Done correctly, it can transform dormant intellectual property into a durable revenue stream. Done poorly, it can create reputational risk, misaligned incentives, and wasted capital.

1.   Patents are financial assets, not just legal instruments.

Senior leadership frequently misunderstands patents. At their core, these assets represent exclusive rights to foundational technological innovations. Whereas most companies know how much they spend on patents, they do not know what those patents are worth, who might be using the underlying technology, or whether monetization is realistic.

As portfolios scale—from a handful of filings to hundreds of patents across multiple jurisdictions—costs scale as well. Annuities, maintenance fees, prosecution costs, and legal spend compound year after year. Eventually, boards and executives ask the inevitable questions:

  • Do we need all of these patents?
  • What do they actually cover?
  • Are they valuable to anyone besides us?
  • If so, what can we do to generate revenue?

The answers to these questions depend on a rigorous understanding of the patent portfolio, as well as the markets underpinning the technologies disclosed therein.

2.   Can your company get comfortable with monetization?

The goal of patent monetization is straightforward: using the company’s patents to generate revenue instead of cost. There are different theoretical paths to achieving this objective. Some companies sell patents to an operating company or non-practicing entity. Others choose licensing, either in-house or via a licensing partner. And still others get creative, trying things like transferring to a start-up for equity.

In my experience, the only consistently successful monetization path is licensing. And with very few exceptions, high value licensing requires a litigation process to successfully resolve. This is by design. By requiring litigation as a pre-requisite to high value licensing, potential licensees significantly limit the pool of patent owners capable of seeing a licensing negotiation through to the end. Because of this paradigm, “friendly licensing” does not work.

Many smart people have tried non-litigation, patent monetization strategies. Success has not followed. Sales to fellow operating companies are hard to close and only generate limited sums. And most of the creative strategies designed to avoid litigation have failed to gain momentum.

If considering monetization, companies thus need to realize that litigation will be needed to “play the game.” There has been an evolution among corporate entities with respect to this reality, as there seems to be more comfort today with the litigation aspect of patent licensing. Perhaps the litigation-based licensing paradigm has become so entrenched, and utilized by so many name brand companies, that it no longer seems controversial.

3.   Is your company’s patent portfolio monetizable?

When companies get comfortable with the prospect of monetization, the inevitable next inquiry is “do we even own patents that can even be monetized?”

The answer lies in the market’s adoption of your company’s patented technologies. Most patents start as what we might call “good idea” patents. The goal is defensive protection for the company’s own technologies. Over time, however, the market may have adopted your technologies. When this happens, the patents covering your adopted technologies become infringed patents.

Monetization potential overwhelmingly resides in infringed patents.

To summarize:

Good Idea Patents

  • Cover technologies developed and used internally
  • Have not been widely adopted by third parties
  • Often valuable defensively to the company, but rarely monetizable

Market-Adopted (Infringed) Patents

  • Cover technologies broadly used by industry participants or standards
  • Create licensing leverage
  • Form the backbone of successful monetization campaigns

While the patent valuation industry can produce impressive-looking numbers for “good idea” patent portfolios, my experience is that real-world licensing markets rarely support those valuations. Licensees just do not pay meaningful consideration for technology they do not use.

Companies interested in monetization are thus well-advised to dedicate the budget and time necessary to determine market adoption. Otherwise, any discussion of monetization value is speculative. I recommend beginning the process internally. Engineers and inventors often possess deep, underutilized knowledge of how technologies have migrated into the broader market. External support is also often called for. Service providers—attorneys and consultants—and newer AI tools can be instrumental in testing claim scope and mapping claims to products.

I would also note that infringement is not the end of the story. For third parties to see merit in licensing your patents, additional factors matter. Patent life is extremely important, with increased licensing potential resulting from portfolios with meaningful remaining life. The scope of infringement is also extremely important. Monetizing a single, infringed patent is nearly impossible. Monetizing hundreds of infringed patents is infinitely more likely to succeed. Finally, geographic scope remains extremely important. While the US remains the epicenter of most infringing activity, portfolios with European coverage are more likely to be monetized.

4.   Just because you can monetize, should you?

Just because your patents can be monetized, doesn’t mean they should be. As discussed, patent monetization often means litigation. Litigation brings the risk of counterclaims, as well as risk to your patents, particularly in the form of invalidity. If you cannot take this risk, monetization may not be right for you (or may be best accomplished through a partner, as explained below).

For larger corporates, risks are often more manageable because of their portfolio’s sheer size. Product lines may have been discontinued, such that risking the underlying patents does not pose a corporate threat. Legacy technologies may no longer be the corporate goal. And core products may just have so much patent coverage that it is possible to monetize groups of assets without risking the defensive coverage for the product.

For smaller companies, monetization often becomes an unplanned for necessity. In a company’s infancy, precious resources are devoted to building product and hiring engineers. But for many the fateful day comes when sharing the secret sauce — either through a joint venture arrangement, corporate partnership or potential M&A — leads to theft of its most critical technologies. With no realistic means to compete with the scale and resources of those who take instead of pay, the company and its investors must rely on the patent portfolio to achieve equity. In this situation, there is little point to holding assets back.

5.   Choosing a monetization path

Assuming potential value, companies must confront another consequential decision: whether to pursue monetization in-house or through a strategic licensing partner.

In-House Monetization

Pursuing a monetization campaign in the company’s own name often seems the simplest approach. That way, control, and upside remain within the company. But so does the risk and significant expense of a monetization campaign. As highlighted above, the reality of the patent market is that high value licensing deals require litigation to close. Such litigation is complex, very expensive and introduces the risk of counterclaims to the patent owner. For this reason, companies that pursue in-house monetization programs are those with experienced licensing and monetization professionals, the ability to manage significant litigation, and access to significant capital to fund the program.

For companies without the requisite resources or possessing a strategic reason for wanting to spin out control and revenue creation, the outsourced model for monetization makes sense.

Outsourced Monetization

Outsourced monetization involves transferring the relevant, to-be monetized patent portfolio to a licensing partner, such as a non-practicing entity. This licensing partner sets up a new entity (typically an LLC) with the corporate purpose of maximizing the portfolio’s revenue. Governance is also established through the entity’s organizational charter.

Though emotionally difficult, the original patent owner is typically not very involved once patents are transferred. Control creates legal risk because external attempts to exert control can undermine important patent legal doctrines with respect to standing. Some owners mitigate risk by granting licenses to important relationships prior to transfer, or (rarely) appointing a representative to a governance board of the newly formed entity. But in most cases, owners must accept relinquishing operational control in exchange for economic participation.

This lack of control also makes partner quality central to reputational and economic outcomes. I cannot emphasize enough that the supply of companies wishing to monetize their IP far surpasses the supply of quality licensing teams with track records that pass institutional muster.

If issues of control can be resolved, financial terms take center stage. Some owners prefer a clean, all cash upfront sale; others participate via a continuing net revenue share. Still other patent owners prefer a combination of upfront consideration plus a continuing net revenue share. Where there is no upfront payment, net revenue shares can approach 50%; where upfront payments are significant, net revenues shares are typically lower.

Given the stakes, the definition of “net revenue” (or “net proceeds”) is a central term in the deal. Because revenue shares are paid from “net proceeds,” the original patent owner often seeks to limit deductible expenses. Licensing teams, on the other hand, demand flexibility to deduct substantial litigation and financing costs. Clarity is a necessity because ambiguity on the “net revenue” formula can be one of the most common sources of post-transaction disappointment.

Monetization Structure Comparison

6.   Financing patent monetization

Whether monetization is pursued in-house or outsourced, significant capital is required to handle potential upfront consideration to the patent owner, as well as the expense of inevitable litigation. For even the most sophisticated patent owners, large licensing outcomes can require complex, multi-jurisdiction litigation. Single case budgets can exceed $10mm, and legal fee structures are anything but uniform.

Because many companies cannot or will not fund these expenses, outside capital is common. Hedge funds, private credit funds, and litigation finance funds can be potential sources of capital. Some funds will only finance litigation expenses; others are more flexible and provide IP-specific or general operating capital.

Recommendations for a Successful Deal

As in other asset classes, choosing the right financing partner, with the right deal structure, is critical. On this front, I offer several suggestions:

Engage the Financing Source Early in the Process

It is very important to bring in the capital provider before, or in parallel with, agreeing to deals with a licensing agent. This is because reputable financial firms will have definite ideas on pricing, structure and protections that a deal will need to reliably close. Bringing in a capital partner early also ensures a smoother path to close, since the ultimate economics and structure are much more to be agreeable to an investor if that investor was involved in the entire process.

Insist on Patent Expertise

I cannot emphasize enough the importance of finding a capital partner with significant experience financing patent infringement litigation or licensing situations. Investing in patent licensing campaigns requires a very specialized understanding of technology, patent law and patent licensing. Without such expertise, ideal outcomes can be hard to achieve. Deals drag or do not close at all, risk is not appropriately priced, structures that align incentives are not achieved, and investor expectations can sour if licensing takes longer or is “lumpier” that expected.

Investors with significant patent experience will also add value far beyond capital. Though they do not control licensing campaigns, patent-centric investors can help pick the right law firm and offer suggestions for structuring that law firm’s ultimate economic deal. Patent savvy investors can also help you choose the right licensing partners, or provide advice on issues related to the ultimate licensing campaign.

Make Sure Incentives are Aligned

Of paramount importance is ensuring that economic incentives are aligned. The most common downfall that I see in deals to finance licensing campaigns is a misalignment of incentives between the patent owner and the investor. This misalignment occurs in the “waterfall” that governs how proceeds are shared between investor, patent owner and law firm. Before sharing with other parties to the deal, many (but not all) investors insist on receiving at least 100% of licensing revenues until invested capital has been returned. Beyond that, things can differ dramatically among different investors.

If the waterfall is not properly constructed and prevents the patent owner from seeing return as soon as possible, unideal outcomes result. To understand the issue, imagine that an investor provides $10mm in funding for legal fees associated with monetization and requires the first 2x of recoveries before sharing with patent owner. Now imagine that a potential licensee offers $20mm for a perpetual license to the portfolio. This would be a great deal for the investor but a terrible deal for the patent owner, who will see no money from the deal. And because the patent owner must control the monetization, no deal will be reached.

Consider Insurance

One of the most recent additions to the patent licensing landscape is contingency risk insurance. In its most basic form, a contingency liability insurance policy allows patent owners to submit a claim at a time certain if pre-agreed patent licensing revenues have not been achieved. These policies are expensive, and place significant obligations on patent owners, but can provide significant access to favorably priced capital. This is because the insurance policy itself can serve as collateral to a credit investor, and markets traditionally view A-rated insurance paper as less risky that litigation outcomes.

Insurance policies also offer attractive refinancing opportunities to patent owners. After success has been achieved in a licensing campaign, for instance, the insurance markets may be willing to offer insurance coverage to a company that already had closed a traditional litigation finance deal. With this policy in hand, the patent owner can pursue a more reasonably priced credit facility to refinance the original funder and carry on with the campaign.

7.   Create an opportunity to unlock value.

Patent monetization is available to those rare companies with the engineering prowess to develop technologies that markets choose to adopt. It is also a consequential corporate decision that implicates reputation, counterparty relationships, and capital allocation. For some companies, monetization is not the preferred path. But for those willing to approach patent monetization with rigor, realism, and the right partners, the exercise represents an underappreciated opportunity to unlock significant, latent value from existing assets.

Image Source: Deposit Photos
Image ID: 6068697
Image Author:archideaphoto

Share

Warning & Disclaimer: The pages, articles and comments on IPWatchdog.com do not constitute legal advice, nor do they create any attorney-client relationship. The articles published express the personal opinion and views of the author as of the time of publication and should not be attributed to the author’s employer, clients or the sponsors of IPWatchdog.com.

Join the Discussion

7 comments so far. Add my comment.

  • [Avatar for Doreen Trujillo]
    Doreen Trujillo
    March 20, 2026 10:31 am

    “In my experience, the only consistently successful monetization path is licensing. And with very few exceptions, high value licensing requires a litigation process to successfully resolve. This is by design. By requiring litigation as a pre-requisite to high value licensing, potential licensees significantly limit the pool of patent owners capable of seeing a licensing negotiation through to the end. Because of this paradigm, “friendly licensing” does not work.”

    Platform technologies may follow a different paradigm. I am thinking Stanford and the Cohen-Boyer patents for recombinant DNA technology. Annual fees and royalty rates were kept reasonable.

    Not sure that would work today, however.

  • [Avatar for Anni Huang]
    Anni Huang
    March 19, 2026 10:39 pm

    Great Article! My professor recommended it and it was a great read and loved the flow of concepts

  • [Avatar for Steven Weiner]
    Steven Weiner
    March 19, 2026 02:16 pm

    We’ll definitely read and discuss this insightful, pragmatic article in the course I teach on IP Strategy for business and engineering students. Thank you for writing and posting it!

  • [Avatar for Stephen T Schreiner]
    Stephen T Schreiner
    March 19, 2026 12:48 pm

    Nice article. The opening premise ” Patents are financial assets, not just legal instruments,” is fundamental but not always fully appreciated. Director Squires has written in the past about patents being derivative assets (analogous to other financial derivatives) with the challenge being how to valuate them. There is no market, as such, other than the licensing/litigation market … That’s what makes building a program within a company to monetize these assets such a challenge…

  • [Avatar for Bruce Berman]
    Bruce Berman
    March 19, 2026 08:53 am

    Useful, informative article; should be required reading for business school grads.

  • [Avatar for Doug Pittman]
    Doug Pittman
    March 18, 2026 02:49 pm

    This is not what, how or why 1.8.8 of our Constitution is intended and was written for protecting inventors.

    Imagine our founding fathers seeing this well written piece but so disgusting patent world in 2026.

    This makes my head spin.

    As I’ve said, A patent is only as good as its first lawsuit.

    No one will license with a small business and inventor without legal actions.

    And that’s what this was about.

    It’s basically useless !

  • [Avatar for Anon]
    Anon
    March 18, 2026 10:50 am

    A greatly detailed and very informative article, but yikes: “In my experience, the only consistently successful monetization path is licensing. And with very few exceptions, high value licensing requires a litigation process to successfully resolve.

    That’s going to be a difficult ‘sell**’ for many small organizations.

    ** I recognize the adage of “Patents are King’s game” but we really should be aiming to not have that adage being a default.

Add Comment

Your email address will not be published. Required fields are marked *

Varsity Sponsors

IPWatchdog Events

Industry Events

PIUG 2026 Joint Annual and Biotechnology Conference
May 19 @ 8:00 am - May 21 @ 5:00 pm EDT
Certified Patent Valuation Analyst Training
May 28 @ 9:00 am - May 29 @ 5:00 pm EDT
2026 WIPO-U.S. Summer School on Intellectual Property
June 1 @ 9:00 am - June 12 @ 1:45 pm EDT

From IPWatchdog